Superluminal Medicines vs West Pharmaceutical Services

Side-by-side comparison of AI visibility scores, market position, and capabilities

West Pharmaceutical Services leads in AI visibility (92 vs 86)
Superluminal Medicines logo

Superluminal Medicines

LeaderHealthcare

General

Boston AI GPCR drug discovery with $1.3B Eli Lilly collaboration Aug 2025 for obesity/cardiometabolic; $158M total ($120M RA Capital/Insight/NVIDIA/Lilly Series A Sep 2024) with MC4R obesity program advancing to IND competing with Relay Therapeutics.

AI VisibilityBeta
Overall Score
A86
Category Rank
#85 of 1158
AI Consensus
59%
Trend
stable
Per Platform
ChatGPT
83
Perplexity
80
Gemini
93

About

Superluminal Medicines is a Boston-based biotechnology company — backed with approximately $158 million in total funding including a $33 million seed in 2023 and a $120 million Series A in September 2024 led by RA Capital Management with Insight Partners, NVIDIA's NVentures, and Eli Lilly — developing AI-driven small molecule drugs targeting G protein-coupled receptors (GPCRs), combining artificial intelligence, protein dynamics simulation, and structural biology to discover drugs for 70% of GPCRs that currently remain "undruggable" despite GPCRs representing the target class for approximately 35% of all FDA-approved drugs. In August 2025, Superluminal secured a landmark $1.3 billion collaboration agreement with Eli Lilly to discover small molecule therapeutics for obesity and cardiometabolic diseases, and is advancing its lead internal MC4R agonist program (for obesity treatment) toward IND-enabling studies with human trials expected Q4 2026. Founded in 2022.

Full profile
West Pharmaceutical Services logo

West Pharmaceutical Services

LeaderHealthcare Tech

Pharmaceutical Packaging

West Pharmaceutical Services (WST) reported ~$3.0B revenue in FY2024. Designs packaging components and delivery systems for injectable drugs — critical for vaccine and biologic drug manufacturing. HQ: Exton, PA.

AI VisibilityBeta
Overall Score
A92
Category Rank
#1 of 1
AI Consensus
71%
Trend
up
Per Platform
ChatGPT
92
Perplexity
88
Gemini
98

About

West Pharmaceutical Services, Inc. is the global leader in packaging components and delivery systems for injectable medications, designing and manufacturing the stoppers, closures, caps, and drug delivery systems that seal vials, syringes, and cartridges containing vaccines, biologics, and injectable drugs. Every major pharmaceutical company and biologic manufacturer relies on West's containment solutions — the small rubber stopper sealing an mRNA vaccine vial or insulin cartridge is almost certainly a West product.

Full profile

AI Visibility Head-to-Head

86
Overall Score
92
#85
Category Rank
#1
59
AI Consensus
71
stable
Trend
up
83
ChatGPT
92
80
Perplexity
88
93
Gemini
98
83
Claude
96
95
Grok
87

Key Details

Category
General
Pharmaceutical Packaging
Tier
Leader
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only West Pharmaceutical Services
Pharmaceutical Packaging

Integrations

Only Superluminal Medicines
Only West Pharmaceutical Services
West Pharmaceutical Services is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.